Report highlights boost to asthma treatment
A new report showcases the impact of a programme to improve access in the North West Coast to a simple test for asthma diagnosis.
The Fractional exhaled Nitric Oxide, or FeNO, tests are non-invasive and measure the amount of nitric oxide in an exhaled breath, which is a biomarker for airway inflammation.
FeNO testing can improve patient care by delivering a faster and more effective asthma diagnosis, when viewed alongside a patient’s clinical history, and can be used to monitor an individual’s response to treatment.
The Innovation Agency supported the testing of thousands of individuals in primary care settings in Lancashire, south Cumbria, Cheshire and Merseyside during the two-year programme.
The Innovation Agency supported the delivery of thousands of tests in Lancashire, south Cumbria, Cheshire and Merseyside during the two-year programme.
And the programme enabled 1,829 people in the region to benefit from a more accurate and faster diagnosis of asthma.
The Innovation Agency’s Clinical Director Andrew Cooper yesterday said:
“Asthma can be a very debilitating condition, so we’re pleased to have played our part in ensuring a faster and more accurate diagnosis for many patients.
“We worked hard with our colleagues in primary care to make sure the test was available to as many people as possible. It’s great that the collaboration has had such a tangible impact.”
The programme was delivered nationally by the Innovation Agency and our partner Academic Health Science Networks (AHSNs). Around 58,000 new asthmatics received a faster and more accurate diagnosis because of FeNO testing, while 1,200 FeNO devices were introduced into primary care use in England.
The programme, led by Wessex AHSN, saw AHSNs work with their systems to support asthma pathway improvements by providing specialist implementation support and clinical leadership, sharing best practice and developing supporting materials for those involved in asthma care.
A FeNO implementation toolkit, which provided practical advice and support for teams adopting FeNO testing, was viewed more than 13,500 times and remains available for NHS staff.
Joe Sladen, Associate Director Innovation Adoption and FeNO lead, Wessex AHSN, yesterday said:
“The national FeNO programme has had a significant impact on improving access to FeNO testing across England, enabling more patients to benefit from a faster and more accurate asthma diagnosis. We’re excited to share our end of programme report and showcase our impact, learnings and overall reflections with our NHS colleagues, industry partners and patients.”
AHSNs in England supported the adoption and spread of FeNO under the NHS England Accelerated Access Collaborative’s (AAC) Rapid Uptake Products Programme.
Read the FeNO programme impact report on the Wessex AHSN website: https://wessexahsn.org.uk/projects/604/feno-programme-impact
Emma Thompson, from Aldershot in Hampshire, shared her experience of severe asthma in support of the programme. You can watch Emma’s story here: https://player.vimeo.com/video/820429693
Latest News from
Incubating new AI ideas in Cheshire and Merseyside to improve health care delivery06/12/2023 15:15:00
C2-Ai and Health Innovation NWC’s collaboration with Cheshire and Merseyside ICB continues to grow from strength to strength.
Driving successful innovation rollout04/12/2023 12:25:00
A new guide to innovation implementation, readiness and resourcing was recently published sharing practical learning from the Health Innovation Network’s successful adoption and spread of the national Focus ADHD programme.
Senior NHS leader takes innovation Chair role23/11/2023 12:25:00
A senior leader with 38 years’ experience in the NHS has taken over as Chair of Health Innovation North West Coast.
Simple AI tools help save money and reduce waiting lists in Lancashire and South Cumbria10/11/2023 09:10:00
ChatBot is saving money and reducing waiting lists for patients waiting for surgery in Lancashire and South Cumbria says an evaluation report with Health Innovation North West Coast.
Boosting maternity and neonatal services07/11/2023 14:10:00
Our Maternity and Neonatal Safety Improvement Programme (MatNeoSIP) team and the North West NeoNatal Operational Delivery Network (NWODN) have been supporting maternity and neonatal teams across the North West to implement the optimisation of the pre-term infant care bundle.
Successes of the MatNeo collaboration in the North West07/11/2023 09:10:00
Blog posted by: Amanda Andrews, 06 November 2023.
Reducing the number of instruments on surgical trays and why this matters17/10/2023 12:25:00
Reducing the environmental impact of operating theatres is one way the NHS can reach its "Net Zero Supply Chain by 2045" ambition.
Introducing Health Innovation North West Coast03/10/2023 09:10:00
The Innovation Agency has been renamed Health Innovation North West Coast.